We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
-2.66%
1 Year Est. Return
+36.93%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.54B
AUM Growth
-$617M
Cap. Flow
-$342M
Cap. Flow %
-4.54%
Top 10 Hldgs %
26.64%
Holding
556
New
16
Increased
233
Reduced
289
Closed
8

Top Buys

Rank Stock Value
1
MDLZ icon
Mondelez International
MDLZ
+$10.7M
2
BAH icon
Booz Allen Hamilton
BAH
+$10.1M
3
KVUE icon
Kenvue
KVUE
+$8.04M
4
ACM icon
Aecom
ACM
+$7.04M
5
FTV icon
Fortive
FTV
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 30.84%
2 Healthcare 16.01%
3 Financials 13.88%
4 Consumer Discretionary 10.32%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
301
Waters Corp
WAT
$41B
$5.18M 0.07%
18,882
+5,300
+39% +$1.46M
NDAQ icon
302
Nasdaq
NDAQ
$49.9B
$5.18M 0.07%
106,523
-8,100
-7% -$410K
DELL icon
303
Dell
DELL
$346B
$5.15M 0.07%
74,756
+5,300
+8% +$316K
ECL icon
304
Ecolab
ECL
$77B
$5.13M 0.07%
30,300
-19,000
-39% -$3.46M
VMC icon
305
Vulcan Materials
VMC
$32.3B
$5.09M 0.07%
25,200
+16,700
+196% +$3.63M
EBAY icon
306
eBay
EBAY
$48.1B
$5.05M 0.07%
114,624
+10,700
+10% +$477K
SJM icon
307
J.M. Smucker
SJM
$13B
$5.04M 0.07%
40,997
+3,400
+9% +$483K
PHM icon
308
Pultegroup
PHM
$22.8B
$5.04M 0.07%
68,007
-900
-1% -$71.7K
ALNY icon
309
Alnylam Pharmaceuticals
ALNY
$31.9B
$5.03M 0.07%
28,415
-100
-0.4% -$19.1K
NBIX icon
310
Neurocrine Biosciences
NBIX
$15.2B
$5.03M 0.07%
44,700
+7,800
+21% +$821K
XYZ
311
Block Inc
XYZ
$47B
$5.03M 0.07%
113,537
+8,800
+8% +$545K
WST icon
312
West Pharmaceutical
WST
$25.7B
$4.99M 0.07%
13,291
-1,600
-11% -$619K
NDSN icon
313
Nordson
NDSN
$17.2B
$4.98M 0.07%
22,301
+300
+1% +$71.8K
TTWO icon
314
Take-Two Interactive
TTWO
$39.6B
$4.92M 0.07%
35,069
-400
-1% -$57.6K
MTD icon
315
Mettler-Toledo International
MTD
$26.7B
$4.88M 0.06%
4,406
+200
+5% +$245K
TAP icon
316
Molson Coors Class B
TAP
$7.32B
$4.88M 0.06%
76,766
+3,900
+5% +$254K
EG icon
317
Everest Group
EG
$14.6B
$4.86M 0.06%
13,087
-300
-2% -$109K
BR icon
318
Broadridge
BR
$19.4B
$4.86M 0.06%
27,142
-11,000
-29% -$1.95M
HAS icon
319
Hasbro
HAS
$12.7B
$4.83M 0.06%
73,034
-5,700
-7% -$377K
FOXA icon
320
Fox Class A
FOXA
$28.4B
$4.82M 0.06%
154,388
+14,800
+11% +$486K
KIM icon
321
Kimco Realty
KIM
$15.4B
$4.81M 0.06%
273,574
+38,500
+16% +$747K
ARES icon
322
Ares Management
ARES
$29.4B
$4.77M 0.06%
46,400
+400
+0.9% +$40.5K
STE icon
323
Steris
STE
$20.5B
$4.73M 0.06%
21,562
+3,100
+17% +$701K
HBAN icon
324
Huntington Bancshares
HBAN
$33.8B
$4.72M 0.06%
453,486
-50,600
-10% -$568K
WBD icon
325
Warner Bros
WBD
$70.3B
$4.71M 0.06%
433,600
-14,500
-3% -$181K

Similar funds

Fjarde Ap-fonden's Q3 2023 Portfolio in Review

As of Q3 2023, Fjarde Ap-fonden held 556 positions worth $7.54B, down 7.6% from $8.16B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Fjarde Ap-fonden withdrew a net $342M in Q3 2023, closing 8 positions and reducing 289 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $84.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Fjarde Ap-fonden opened a new position in Mondelez International worth $10.3M.

  • Fjarde Ap-fonden's largest Q3 2023 buy was Mondelez International: 148,395 shares worth $10.3M.
  • Fjarde Ap-fonden added most to Edison International in Q3 2023, an estimated $4.81M increase.
  • Fjarde Ap-fonden's biggest Q3 2023 reduction was Apple, cutting an estimated $31.5M.
  • Fjarde Ap-fonden fully exited iShares MSCI USA Value Factor ETF in Q3 2023, selling an estimated $84.4M.
  • Fjarde Ap-fonden's ten largest holdings make up 27% of its $7.54B portfolio in Q3 2023.
  • Fjarde Ap-fonden opened 16 new positions and closed 8 in Q3 2023.
  • Fjarde Ap-fonden's portfolio value fell 7.6% quarter-over-quarter to $7.54B.

Based on Fjarde Ap-fonden's 13F filing for Q3 2023, filed 23 Oct 2023.